This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 2b, Double-blind, Randomized, Placebo-cont...
Clinical trial

A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in subjects with Gastroesophageal Reflux Disease (GERD) with Persistent Regurgitation W

Read time: 1 mins
Last updated:17th Apr 2012
To evaluate the effect of 3 doses of SSP-002358 on the symptom of regurgitation compared with placebo
Category Value
Study start date 2012-04-17

View full details